Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion

Matyas Koltai, A. Tósaki, David Hosford, Pierre Braquet

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The effect of ginkgolide B (BN 52021), a specific platelet-activating factor (PAF) antagonist, applied in doses of 1.5, 3.0, 6.0 × 10-5 and 1.2 × 10-4 mol/l, in comparison to that of metoprolol (10-5 mol/l) and diltiazem (10-7 mol/l), two widely used antiarrhythmic agents, on ischemia- and reperfusion-induced arrhythmias and heart functions, such as heart rate (HR), coronary flow (CF), aortic flow (AF), left ventricular developed pressure (LVDP), its first derivative (LVdp/dtmax), and left ventricular end-diastolic pressure (LVEDP) in isolated working rat hearts was examined. BN 52021 caused a dose-related protection against dysrhythmias, such as ventricular fibrillation, ventricular tachycardia, and premature ventricular beats induced by ischemia (30 min ligation of the left anterior descending coronary artery). the antiarrhythmic effect of BN 52021 given in a dose of 6.0 × 10-5 mol/l was comparable to that of diltiazem and superior to the activity of metoprolol. None of the drugs influenced reperfusion-induced rhythm disturbances. BN 52021 did not alter heart functions, while metoprolol reduced (LVEDP only, and diltiazem increased CF, decreased AF, LVDP, and LVdp/dtmax during regional ischemia, indicating a negative inotropic effect. The antiarrhythmic effect of BN 52021 appears to be related to an antagonism of an increase in slow calcium influx induced by PAF in myocardial cells. Similarly to the mechanism of action of established antiarrhythmic drugs, BN 52021 can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances.

Original languageEnglish
Pages (from-to)293-302
Number of pages10
JournalEuropean Journal of Pharmacology
Volume164
Issue number2
DOIs
Publication statusPublished - May 19 1989

Fingerprint

ginkgolide B
Reperfusion
Cardiac Arrhythmias
Ischemia
Metoprolol
Diltiazem
Platelet Activating Factor
Ventricular Pressure
Blood Pressure
Ventricular Premature Complexes
Anti-Arrhythmia Agents
Ventricular Fibrillation
Ventricular Tachycardia
Ligation

Keywords

  • (Rat)
  • Arrhythmias
  • BN 52021
  • Heart functions
  • Ischemia and reperfusion
  • Platelet activating factor (PAF-acether, PAF)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion. / Koltai, Matyas; Tósaki, A.; Hosford, David; Braquet, Pierre.

In: European Journal of Pharmacology, Vol. 164, No. 2, 19.05.1989, p. 293-302.

Research output: Contribution to journalArticle

Koltai, Matyas ; Tósaki, A. ; Hosford, David ; Braquet, Pierre. / Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion. In: European Journal of Pharmacology. 1989 ; Vol. 164, No. 2. pp. 293-302.
@article{e58741dfe27349979a71a17eea5644df,
title = "Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion",
abstract = "The effect of ginkgolide B (BN 52021), a specific platelet-activating factor (PAF) antagonist, applied in doses of 1.5, 3.0, 6.0 × 10-5 and 1.2 × 10-4 mol/l, in comparison to that of metoprolol (10-5 mol/l) and diltiazem (10-7 mol/l), two widely used antiarrhythmic agents, on ischemia- and reperfusion-induced arrhythmias and heart functions, such as heart rate (HR), coronary flow (CF), aortic flow (AF), left ventricular developed pressure (LVDP), its first derivative (LVdp/dtmax), and left ventricular end-diastolic pressure (LVEDP) in isolated working rat hearts was examined. BN 52021 caused a dose-related protection against dysrhythmias, such as ventricular fibrillation, ventricular tachycardia, and premature ventricular beats induced by ischemia (30 min ligation of the left anterior descending coronary artery). the antiarrhythmic effect of BN 52021 given in a dose of 6.0 × 10-5 mol/l was comparable to that of diltiazem and superior to the activity of metoprolol. None of the drugs influenced reperfusion-induced rhythm disturbances. BN 52021 did not alter heart functions, while metoprolol reduced (LVEDP only, and diltiazem increased CF, decreased AF, LVDP, and LVdp/dtmax during regional ischemia, indicating a negative inotropic effect. The antiarrhythmic effect of BN 52021 appears to be related to an antagonism of an increase in slow calcium influx induced by PAF in myocardial cells. Similarly to the mechanism of action of established antiarrhythmic drugs, BN 52021 can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances.",
keywords = "(Rat), Arrhythmias, BN 52021, Heart functions, Ischemia and reperfusion, Platelet activating factor (PAF-acether, PAF)",
author = "Matyas Koltai and A. T{\'o}saki and David Hosford and Pierre Braquet",
year = "1989",
month = "5",
day = "19",
doi = "10.1016/0014-2999(89)90470-6",
language = "English",
volume = "164",
pages = "293--302",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion

AU - Koltai, Matyas

AU - Tósaki, A.

AU - Hosford, David

AU - Braquet, Pierre

PY - 1989/5/19

Y1 - 1989/5/19

N2 - The effect of ginkgolide B (BN 52021), a specific platelet-activating factor (PAF) antagonist, applied in doses of 1.5, 3.0, 6.0 × 10-5 and 1.2 × 10-4 mol/l, in comparison to that of metoprolol (10-5 mol/l) and diltiazem (10-7 mol/l), two widely used antiarrhythmic agents, on ischemia- and reperfusion-induced arrhythmias and heart functions, such as heart rate (HR), coronary flow (CF), aortic flow (AF), left ventricular developed pressure (LVDP), its first derivative (LVdp/dtmax), and left ventricular end-diastolic pressure (LVEDP) in isolated working rat hearts was examined. BN 52021 caused a dose-related protection against dysrhythmias, such as ventricular fibrillation, ventricular tachycardia, and premature ventricular beats induced by ischemia (30 min ligation of the left anterior descending coronary artery). the antiarrhythmic effect of BN 52021 given in a dose of 6.0 × 10-5 mol/l was comparable to that of diltiazem and superior to the activity of metoprolol. None of the drugs influenced reperfusion-induced rhythm disturbances. BN 52021 did not alter heart functions, while metoprolol reduced (LVEDP only, and diltiazem increased CF, decreased AF, LVDP, and LVdp/dtmax during regional ischemia, indicating a negative inotropic effect. The antiarrhythmic effect of BN 52021 appears to be related to an antagonism of an increase in slow calcium influx induced by PAF in myocardial cells. Similarly to the mechanism of action of established antiarrhythmic drugs, BN 52021 can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances.

AB - The effect of ginkgolide B (BN 52021), a specific platelet-activating factor (PAF) antagonist, applied in doses of 1.5, 3.0, 6.0 × 10-5 and 1.2 × 10-4 mol/l, in comparison to that of metoprolol (10-5 mol/l) and diltiazem (10-7 mol/l), two widely used antiarrhythmic agents, on ischemia- and reperfusion-induced arrhythmias and heart functions, such as heart rate (HR), coronary flow (CF), aortic flow (AF), left ventricular developed pressure (LVDP), its first derivative (LVdp/dtmax), and left ventricular end-diastolic pressure (LVEDP) in isolated working rat hearts was examined. BN 52021 caused a dose-related protection against dysrhythmias, such as ventricular fibrillation, ventricular tachycardia, and premature ventricular beats induced by ischemia (30 min ligation of the left anterior descending coronary artery). the antiarrhythmic effect of BN 52021 given in a dose of 6.0 × 10-5 mol/l was comparable to that of diltiazem and superior to the activity of metoprolol. None of the drugs influenced reperfusion-induced rhythm disturbances. BN 52021 did not alter heart functions, while metoprolol reduced (LVEDP only, and diltiazem increased CF, decreased AF, LVDP, and LVdp/dtmax during regional ischemia, indicating a negative inotropic effect. The antiarrhythmic effect of BN 52021 appears to be related to an antagonism of an increase in slow calcium influx induced by PAF in myocardial cells. Similarly to the mechanism of action of established antiarrhythmic drugs, BN 52021 can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances.

KW - (Rat)

KW - Arrhythmias

KW - BN 52021

KW - Heart functions

KW - Ischemia and reperfusion

KW - Platelet activating factor (PAF-acether, PAF)

UR - http://www.scopus.com/inward/record.url?scp=0024360569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024360569&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(89)90470-6

DO - 10.1016/0014-2999(89)90470-6

M3 - Article

VL - 164

SP - 293

EP - 302

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -